• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Athersys

for sale close down for sale sign business
Biotech

Athersys files for bankruptcy, sells assets to Healios

Athersys' last-ditch attempt to salvage the company in the wake of an unsatisfactory trial of its ischemic stroke cell therapy has been unsuccessful.
James Waldron Jan 9, 2024 10:38am
dominoes bankruptcy fall fail trouble knock

Athersys nears bankruptcy as cell therapy fails interim analysis

Oct 10, 2023 10:50am
Woman tears agreement documents in front of agent

Athersys loses funding deal as layoffs allow backer to turn tail

Jul 8, 2022 8:41am
exit sign

Prettying itself up for partners, Athersys lays off 70% of staff

Jun 3, 2022 8:47am
Elderly patient old old age alzheimers parkinsons assisted living hospice

Athersys stock plunges 60% after stroke stem cell therapy miss

May 20, 2022 10:26am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings